VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM), in response to shareholder questions, updates its shareholders on the amount of money received from warrant exercises since April 1, 2018. Since that time CEL-SCI has received $2,133,677 through the exercise of warrants by investors to purchase the Company's common stock. The number of shares outstanding is 19,518,106.
About CEL-SCI Corporation
CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. The Company has operations in Vienna, Virginia, and in/near Baltimore, Maryland.